309 related articles for article (PubMed ID: 33806327)
1. Comprehensive Analysis of Correlations in the Expression of miRNA Genes and Immune Checkpoint Genes in Bladder Cancer Cells.
Stempor PA; Avni D; Leibowitz R; Sidi Y; Stępień M; Dzieciątkowski T; Dobosz P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806327
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNAs in bladder cancer.
Enokida H; Yoshino H; Matsushita R; Nakagawa M
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells.
Zhang S; Chang YY; Gong YW; Gao YJ; Guo Q; Wang YH; Zhao YL; Wang ZP
J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549
[TBL] [Abstract][Full Text] [Related]
4. Global analysis of miRNA-mRNA regulation pair in bladder cancer.
Fan X; Zou X; Liu C; Peng S; Zhang S; Zhou X; Wang T; Zhu W
World J Surg Oncol; 2022 Mar; 20(1):66. PubMed ID: 35241117
[TBL] [Abstract][Full Text] [Related]
5. Correlating bladder cancer risk genes with their targeting microRNAs using MMiRNA-Tar.
Liu Y; Baker S; Jiang H; Stuart G; Bai Y
Genomics Proteomics Bioinformatics; 2015 Jun; 13(3):177-82. PubMed ID: 26169799
[TBL] [Abstract][Full Text] [Related]
6. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
7. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
8. Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Jiang WD; Yuan PC
PLoS One; 2019; 14(8):e0220118. PubMed ID: 31369587
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly expressed microRNAs in the context of bladder tumorigenesis.
Lee JY; Ryu DS; Kim WJ; Kim SJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S52-9. PubMed ID: 27326408
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
Wang L; Wang Y; Wang J; Li L; Bi J
J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131
[TBL] [Abstract][Full Text] [Related]
11. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
[TBL] [Abstract][Full Text] [Related]
12. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database.
Xu Z; Wang C; Xiang X; Li J; Huang J
Med Sci Monit; 2019 Apr; 25():3041-3060. PubMed ID: 31020952
[TBL] [Abstract][Full Text] [Related]
14. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
15. Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network.
Sun Y; Zhu D; Xing H; Hou Y; Liu Y
World J Urol; 2020 Nov; 38(11):2835-2847. PubMed ID: 32060632
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of microRNAs in bladder cancer.
Yoshino H; Seki N; Itesako T; Chiyomaru T; Nakagawa M; Enokida H
Nat Rev Urol; 2013 Jul; 10(7):396-404. PubMed ID: 23712207
[TBL] [Abstract][Full Text] [Related]
17. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
19. Expression of miRNAs involved in angiogenesis, tumor cell proliferation, tumor suppressor inhibition, epithelial-mesenchymal transition and activation of metastasis in bladder cancer.
Zaravinos A; Radojicic J; Lambrou GI; Volanis D; Delakas D; Stathopoulos EN; Spandidos DA
J Urol; 2012 Aug; 188(2):615-23. PubMed ID: 22704449
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.
Li M; Liu Y; Zhang X; Liu J; Wang P
Gene; 2018 Nov; 677():189-197. PubMed ID: 30025927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
